Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493215-25-000053
Filing Date
2025-11-14
Accepted
2025-11-14 08:35:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8779
  Complete submission text file 0001493215-25-000053.txt   10641
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China
Business Address 899 HALEI ROAD BUILDING B, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Subject) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90351 | Film No.: 251481485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)